| Mrs Donna L Vanvark, RPH | |
|
118 Se 9th St, Pella, IA 50219-2200 | |
| (641) 628-1280 | |
| Not Available |
| Full Name | Mrs Donna L Vanvark |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 118 Se 9th St, Pella, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629138581 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 17149 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Donna L Vanvark, RPH 1414 Hazel St, Pella, IA 50219-1002 Ph: (641) 628-2446 | Mrs Donna L Vanvark, RPH 118 Se 9th St, Pella, IA 50219-2200 Ph: (641) 628-1280 |
News Archive
An understanding of particle diffusion in the presence of constrictions is essential in fields as diverse as drug delivery, cellular biology, nanotechnology, materials engineering, and spread of pollutants in the soil. When a driving force is applied, displacement of particles occurs as well as diffusion. A paper in the Journal of Chemical Physics, which is published by the American Institute of Physics (AIP), quantifies the effects of periodic constrictions on drift and diffusion in systems experiencing a driving force.
Results from a Brazilian study suggest that higher levels of intrinsic religiosity are associated with fewer depressive symptoms and increased quality of life in patients with bipolar disorder.
Climate change is according to the WHO the greatest threat to human health in the 21st century. By bringing together leaders in climate change and health research, this international project will contribute with knowledge and policy advice on climate change and health impacts.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. DVT and PE are collectively referred to as venous thromboembolism (VTE).
In this interview, Tim Cross, Director of the NMR and MRI programs at the National High Magnetic Field Lab (NHMFL) in Tallahassee, Florida, talks about his research into protein structures in viruses and bacteria, and how the findings will affect medical research into disease prevention.
› Verified 2 days ago
Allison Dop, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 Monroe St, Pella, IA 50219 Phone: 641-621-2444 Fax: 641-628-2164 | |
Mr. Joel Dean Shields, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1610 Vermeer Rd E, Pella, IA 50219 Phone: 641-621-7470 Fax: 641-621-7471 | |
Tiffany Druivenga, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1650 Washington St, Pella, IA 50219 Phone: 641-628-9227 | |
Joseph Phillip Formaro, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1610 Vermeer Rd E, Plant 3 & 1/2, Pella, IA 50219 Phone: 641-621-7470 Fax: 641-621-7471 | |
Mrs. Susan Kaye Strong, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 118 Se 9th St, Pella, IA 50219 Phone: 641-628-1280 Fax: 641-628-3626 | |
Mr. Thomas Bernard Vander Linden, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 118 Se 9th St, Pella, IA 50219 Phone: 641-628-1280 Fax: 641-628-3626 | |
Dr. Carol Angela Kiser, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 118 Se 9th St, Hy-vee, Pella, IA 50219 Phone: 641-628-1280 Fax: 641-628-3625 |